Two Sigma Advisers’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,483,500	Closed	-$2M	–	2217
2025 Q4	$2M	Buy	1,483,500 +22,300	+2%	+$32.5K	﹤0.01%	1189
2025 Q3	$2.21M	Buy	1,461,200 +185,286	+15%	+$278K	﹤0.01%	1107
2025 Q2	$1.48M	Buy	1,275,914 +433,314	+51%	+$571K	﹤0.01%	1259
2025 Q1	$1.34M	Sell	842,600 -47,100	-5%	-$102K	﹤0.01%	1331
2024 Q4	$2.7M	Sell	889,700 -259,700	-23%	-$851K	0.01%	989
2024 Q3	$4.23M	Buy	1,149,400 +352,500	+44%	+$1.28M	0.01%	767
2024 Q2	$3.26M	Buy	796,900 +695,900	+689%	+$7.77M	0.01%	950
2024 Q1	$1.59M	Buy	+101,000	New	+$1.39M	﹤0.01%	1344
2022 Q4	–	Sell	-22,600	Closed	-$490K	–	2724
2022 Q3	$490K	Sell	22,600 -32,700	-59%	-$894K	﹤0.01%	1850
2022 Q2	$1.55M	Sell	55,300 -13,000	-19%	-$344K	﹤0.01%	1350
2022 Q1	$3.15M	Buy	68,300 +1,500	+2%	+$80.9K	0.01%	1017
2021 Q4	$5.62M	Sell	66,800 -69,300	-51%	-$5.36M	0.01%	714
2021 Q3	$9.07M	Buy	136,100 +81,600	+150%	+$4.71M	0.02%	550
2021 Q2	$2.9M	Buy	54,500 +17,500	+47%	+$937K	0.01%	1120
2021 Q1	$1.6M	Buy	37,000 +23,900	+182%	+$1.03M	﹤0.01%	1383
2020 Q4	$680K	Buy	+13,100	New	+$591K	﹤0.01%	1744